EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	106.14M
Revenue (ttm)	66.87M
Net Income (ttm)	6.73M
Shares Out	47.17M
EPS (ttm)	0.15
PE Ratio	15.46
Forward PE	11.19
Dividend	0.04 (1.43%)
Ex-Dividend Date	May 16, 2025

Volume	276,958
Average Volume	93,839
Open	2.650
Previous Close	2.800
Day's Range	2.250 - 2.680
52-Week Range	1.290 - 3.720
Beta	0.52
RSI	52.72
Earnings Date	Feb 25, 2026

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. Th...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In 2025, EZZ Life Science Holdings's revenue was 66.87 million, an increase of 0.65% compared to the previous year's 66.44 million. Earnings were 6.73 million, a decrease of -3.36%.